Nuvalent (NUVL) Research & Development (2020 - 2026)

Nuvalent has reported Research & Development for 7 years, with the latest figure at $83.6 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development rose 12.35% year-over-year to $83.6 million; the trailing twelve-month figure through Mar 2026 stood at $316.2 million (up 24.69% YoY), and the FY2025 full-year result was $307.0 million, up 40.96% from the prior year.
• Research & Development for Q1 2026 stood at $83.6 million, up from $67.8 million in the prior quarter.
• The five-year high for Research & Development was $83.8 million in Q3 2025, with the low at $12.7 million in Q1 2022.
• Historically, Research & Development has averaged $46.2 million across 5 years, with a median of $38.6 million in 2024.
• Annual changes were most pronounced in 2022 — Research & Development soared 131.46% — and 2025, when it decreased 2.34%.
• Nuvalent's Research & Development stood at $22.9 million in 2022, then jumped by 55.7% to $35.6 million in 2023, then soared by 95.09% to $69.4 million in 2024, then retreated by 2.34% to $67.8 million in 2025, then gained by 23.32% to $83.6 million in 2026.
• The last three Research & Development figures came in at $83.6 million (Q1 2026), $67.8 million (Q4 2025), and $83.8 million (Q3 2025), per Business Quant data.